Published in J Drug Educ on January 01, 2003
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis (2005) 1.80
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res (2007) 1.18
The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. J Urban Health (2004) 1.01
HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates. Public Health Rep (2007) 0.97
Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study. Am J Public Health (2014) 0.81
Hepatitis infection in the treatment of opioid dependence and abuse. Subst Abuse (2008) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health (2006) 4.85
The differential effects of face-to-face and computer interview modes. Am J Public Health (2002) 4.13
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS (2006) 3.55
A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr (2002) 3.20
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis (2011) 3.13
Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction (2004) 2.97
Alternatives to the randomized controlled trial. Am J Public Health (2008) 2.85
Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology (2004) 2.52
Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol (2008) 2.27
A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. J Acquir Immune Defic Syndr (2002) 2.16
Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy (2008) 2.15
Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr (2002) 1.97
Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr (2006) 1.88
'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction (2007) 1.85
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (2002) 1.83
Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr (2002) 1.78
Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. Int J Drug Policy (2006) 1.74
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr (2005) 1.69
Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr (2002) 1.68
Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach. Am J Public Health (2014) 1.62
HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health (2003) 1.55
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health (2004) 1.49
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy (2007) 1.48
Social supporters and drug use enablers: a dilemma for women in recovery. Addict Behav (2002) 1.47
Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend (2008) 1.41
Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat (2003) 1.41
A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat (2002) 1.40
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS (2005) 1.40
Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (2012) 1.38
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health (2008) 1.33
Correlates of HIV status among injection drug users in a border region of southern China and northern Vietnam. J Acquir Immune Defic Syndr (2005) 1.31
Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction (2003) 1.30
An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav (2013) 1.27
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health (2004) 1.26
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend (2007) 1.26
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med (2009) 1.23
Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors. Health Place (2011) 1.23
Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia. J Urban Health (2010) 1.21
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis (2012) 1.20
Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav (2013) 1.20
Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need. J Urban Health (2009) 1.19
HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health (2007) 1.19
Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev (2010) 1.19
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res (2007) 1.18
Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health (2007) 1.18
Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy. Clin Infect Dis (2003) 1.18
Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection. J Hepatol (2011) 1.18
Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes. Int J Drug Policy (2008) 1.17
Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend (2004) 1.17
Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Subst Use Misuse (2011) 1.16
Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health (2002) 1.15
Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. J Infect Dis (2007) 1.14
A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc Sci Med (2008) 1.13
Evaluation of an alternative program for MMTP drop-outs: impact on treatment re-entry. Drug Alcohol Depend (2002) 1.11
Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes. Am J Public Health (2010) 1.11
Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduct J (2009) 1.09
How persons with chronic hepatitis C in residential substance abuse treatment programs think about depression and interferon therapy. J Am Psychiatr Nurses Assoc (2010) 1.09
Hepatitis C knowledge among staff in U.S. drug treatment programs. J Drug Educ (2006) 1.08
Knowledge of hepatitis among active drug injectors at a syringe exchange program. J Subst Abuse Treat (2005) 1.07
A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health (2013) 1.07
Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend (2008) 1.06
Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Educ Behav (2006) 1.06
The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. AIDS Behav (2006) 1.05
Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units. AIDS Patient Care STDS (2005) 1.03
Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. Int J Drug Policy (2008) 1.02
Behavior change and health-related interventions for heterosexual risk reduction among drug users. Subst Use Misuse (2006) 1.02
The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. J Urban Health (2004) 1.01
Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America. Int J Drug Policy (2006) 1.01
Correlates of attempted suicide among young injection drug users in a multi-site cohort. Drug Alcohol Depend (2004) 0.99
On-site HIV testing in residential drug treatment units: results of a nationwide survey. Public Health Rep (2003) 0.97
Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health (2011) 0.96
Controlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and China. PLoS One (2012) 0.95
Sexual health in art and science. Emerg Infect Dis (2006) 0.95
HIV testing and treatment among at-risk drinking injection drug users. J Int Assoc Physicians AIDS Care (Chic) (2009) 0.94
Ethical considerations in surveys employing respondent-driven sampling. Am J Public Health (2010) 0.94
Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries. BMC Health Serv Res (2014) 0.93
Community attitudes toward HIV prevention for injection drug users: findings from a cross-border project in southern China and northern Vietnam. J Urban Health (2005) 0.93
Provision of on-site medical care to patients with hepatitis C in drug treatment units. J Health Care Poor Underserved (2004) 0.92
HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs. AIDS Educ Prev (2005) 0.92
Sexual risk and HIV infection among drug users in New York City: a pilot study. Subst Use Misuse (2011) 0.91
High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam. Psychiatry Res (2012) 0.91
At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. AIDS Patient Care STDS (2009) 0.90
Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S. Drug Alcohol Depend (2005) 0.90
Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients. BMC Public Health (2006) 0.89
Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr (2004) 0.88
Hepatitis vaccination among drug users. Vaccine (2006) 0.88
Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs. Am J Drug Alcohol Abuse (2007) 0.88
Syphilis in drug users in low and middle income countries. Int J Drug Policy (2009) 0.88